Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272)
- 25 July 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 120 (31), 7916-7923
- https://doi.org/10.1021/ja981206r
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatineStructure, 1995
- Protease uninhibitedNature, 1995
- The HIV-1 Protease as Enzyme and Substrate: Mutagenesis of Autolysis Sites and Generation of a Stable Mutant with Retained Kinetic PropertiesBiochemistry, 1994
- Structural engineering of the HIV‐1 protease molecule with a β‐turn mimic of fixed geometryProtein Science, 1993
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structuresJournal of Applied Crystallography, 1991
- Cholinergic activity of acetylenic imidazoles and related compoundsJournal of Medicinal Chemistry, 1991
- Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteinsJournal of the American Chemical Society, 1990
- The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoproteinNature, 1989